AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 91 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $40,000 | +185.7% | 4,000 | +166.7% | 0.02% | +150.0% |
Q1 2018 | $14,000 | -36.4% | 1,500 | 0.0% | 0.01% | -33.3% |
Q4 2017 | $22,000 | -26.7% | 1,500 | 0.0% | 0.01% | -33.3% |
Q3 2017 | $30,000 | +36.4% | 1,500 | 0.0% | 0.02% | +28.6% |
Q2 2017 | $22,000 | +22.2% | 1,500 | -25.0% | 0.01% | +27.3% |
Q1 2017 | $18,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |